Practical issues concerning tear protein assays in dry eye

Area of Science:

• Ophthalmology
• Biochemistry
• Clinical Diagnostics

Background:

• Dry eye disease diagnosis relies on subjective symptoms and clinical signs, complicating treatment decisions, especially in severe cases.
• Current dry eye treatments can be costly, invasive, or have side effects, highlighting the need for objective diagnostic and monitoring methods.
• Discrepancies between clinical signs and symptoms in dry eye patients impede effective treatment assessment.

Purpose of the Study:

• To review the evidence supporting the role of tear proteins in dry eye pathology.
• To explore potential changes in tear protein concentrations during dry eye therapy.
• To evaluate the reliability of tear protein analysis for dry eye diagnosis and treatment monitoring.

Main Methods:

• Review of scientific literature on tear protein biomarkers in dry eye disease.
• Analysis of emerging technologies for tear protein detection, including mass spectrometry and multiplex assays.
• Examination of point-of-care devices for tear protein analysis.

Main Results:

• Tear protein profiles show significant alterations in dry eye disease, reflecting underlying molecular disturbances.
• New technologies like proteomics and multiplex assays enable sensitive detection of tear biomarkers.
• Evidence suggests tear proteins can help differentiate dry eye subtypes and monitor therapeutic responses.

Conclusions:

• Tear protein analysis presents a promising avenue for objective dry eye diagnosis and treatment monitoring.
• Further development of reliable, office-based assays is crucial for integrating tear protein analysis into routine clinical practice.
• Current evidence supports the role of tear proteins in understanding and managing dry eye pathology.